What's new
Fantasy Football - Footballguys Forums

This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

Stock Thread (15 Viewers)

Don't Noonan said:
Another hot IPO this morning.  ZI - Zoominfo Technologies was originally supposed to price in mid teens, then was raised to $19-$20 before finally getting priced at $21.  That usually is a good sign it will do very well today.  Not sure where it will open yet.
Click to expand...
TD had this in the news section:

*ZoomInfo Technologies Shares To Open For Quote At 10:10 a.m. EDT, Expected To Open For Trade At 10:20 a.m.; IPO Priced At $21/Share

Benzinga

 
Don Hutson said:
Tocilizumab has had some bad results in its other trials.  Its safety record isn't impeccable like leronlimab's safety record.  And since the study you are citing isn't double blind, how is it any different than the data that CytoDyn has from its eINDs?   At the end of June, leronlimab's trials will have data from approximately 125 patients in randomized double-blind placebo trials and another 75 from eINDs.  In addition, its safety record will be based on more than 900 patients many of which have taken leronlimab for more than 5 years.  If Patterson has been telling the truth, leronlimab should have clearly better results than tocilizumab.  If Patterson has been lying, we are screwed.  While Nader would do anything for money, I have trouble believing that Patterson would sully his name in order to make a quick buck.
Click to expand...
All good points.

In about 1 month, the tocilizumab 400+ patient Phase 3 trial will be unblinded and shared. The study I referenced supports a clinical benefit, IMO.

It will be very interesting to see Leronlimab’s trial data. But the data will not be a full phase 3 study. For typical drug approval, the FDA does need to see lab data that Paterson is generating. But even more critical is demonstrated patient outcomes. I really doubt partial trial data will support that. And you really can’t combine data from 2 trials.

IMO, If the data is good from these trials, I think the FDA will tell CYDY to go finish your phase 3 trials. The data I saw from the presentation this week isn’t strong enough to skip phase 3.

I’ve gained insights and made $ from this board, so I’m just sharing what I think will happen here. We will find out this summer.

 
Don't Noonan said:
Do Robinhooders usually buy IPOs?  ZI is a marketing company and quite frankly I do not know much more about it.  I do expect it to pop at open (now seeing as high as $45).  Not advising buying at that price but likely some price swings today.
Click to expand...
Bloomberg just said a $45 open price too.  Wow.

 
I'm 52 and seen some crazy markets but this market is the dumbest of all time. It seems dumber than the dotcom and fully expect it to end badly. That said, I'm up 10% from Feb.  and have increased my cash/bonds to 35%. Feel ok with that, but still expect pain when this implodes.

 
Last edited by a moderator:
If BLMN can hit $13 I'm out been holding for awhile when I bought at $9.  I didn't like my entry point at $9 so will be happy to get out.

 
Any thoughts on long term holds involving AI? Prefer ETFs I get that the market might be overpriced, but there's room to grow.

Right now looking at LRNZ or ARKQ. 

 
I don't like JETS...American and United are bad companies.   You are buying bad companies when you buy some of these ETFs.

 
TripItUp said:
I don't like JETS...American and United are bad companies.   You are buying bad companies when you buy some of these ETFs.
Click to expand...
Even though I'm on this JETS ride, I agree about not liking AAL and UAL.  Those two are the #2 and #4 size holdings of JETS making up 20% of the ETF.      

 
Don Hutson said:
Does anyone here use Zoominfo?  If so, is it a good product?
Click to expand...
I do, and yes it's pretty good.  It's essentially a database of companies and business contacts that B2B sales and marketing teams use to identify and target prospects.  It integrates with other systems like LinkedIn Navigator and Salesforce.com, so we use it to pull in contacts and then prospect via email, phone, or Account Based Marketing.  

There are competitors in the space, I've used Hoovers and InsideView in the past.  I don't know enough about those to know the differentiators.

 
TripItUp said:
I think I'd call it profit taking.
Click to expand...
Dunno, the SEC filing came out and it plummeted from 11.50 to 4.70.  In about 30 minutes with several halts.  I'm certain there was profit taking (a few of us here sold this morning around 11 for profit.  We didn't know (I didn't at least) about the filing this morning), but looks a lot like panic selling too.  

 
I still don't understand this market.  Up every day after hundreds of billions of damage.  After 20 years of investing I thought I knew a little but this makes zero sense to me.  Am I venting because I sold low, locked in losses and an going to be be forced in to buying back high, yes.   But honestly I'm more upset that economics no longer makes sense.   I see no reason we should be over Dow 22k.   Things just make a lot less sense in the bailout days

 
Dentist said:
I still don't understand this market.  Up every day after hundreds of billions of damage.  
Click to expand...
You're not on an island here.   A lot of institutional money is on the sidelines right now and is expecting a correction....even with the Fed pumping.

 
Last edited by a moderator:
TripItUp said:
You're not on an island here.   A lot of institutional money is on the sidelines right now and expect a correction....even with the Fed pumping.
Click to expand...
I guess that's my question. If a lot of money is on the sidelines, ready to get in on a dip, how big can that dip really get?

 
beef said:
Does Robinhood flag users for day trading?
Click to expand...
Good question.  They have the same rules, it appears, as others like TD.  3 day trades in a week, unless you have $25k or more in the trading account.  How they flag or enforce it, not sure.

 
TripItUp said:
You're not on an island here.   A lot of institutional money is on the sidelines right now and is expecting a correction....even with the Fed pumping.
Click to expand...
Maybe I'm in the minority of people, I'm going to take a 30 to 40 percent income dip this year.   So I'm going to spend less.  Many people I know are going to spend less.  Maybe that drop in spending doesn't affect the companies in the s and p 500.  Maybe most people aren't having that drop.  But I'm pissed at the double whammy of an income drop and net worth drop

 
You must log in or register to reply here.

Similar threads

Andrew74
2025 FBG Stock Contest
2
Replies
76
Views
4K
SouthJersey
SouthJersey
Andrew74
2024 FBG Stock Contest
2 3
Replies
127
Views
7K
McBokonon
McBokonon
Joey Wright
2025-2026 NCAA College Basketball Thread
Replies
6
Views
155
SpurrierisisGod
SpurrierisisGod

Users who are viewing this thread

Total: 10 (members: 1, guests: 9)
Back
Top